{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:57:03Z","timestamp":1648871823298},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/olq.0b013e3182809776","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T15:43:29Z","timestamp":1361634209000},"page":"292-297","source":"Crossref","is-referenced-by-count":7,"title":["Chlamydia Screening Coverage Estimates Derived Using Healthcare Effectiveness Data and Information System Procedures and Indirect Estimation Vary Substantially"],"prefix":"10.1097","volume":"40","author":[{"given":"Jennifer M.","family":"Broad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa E.","family":"Manhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne P.","family":"Kerani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Scholes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210213","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","article-title":". Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.","volume":"334","author":"Scholes","year":"1996","journal-title":"N Engl J Med"},{"key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/318139","article-title":". Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study.","volume":"31","author":"Ostergaard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R3-8-20210213","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":". Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: The POPI (Prevention of Pelvic Infection) trial.","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"key":"R4-8-20210213","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/153.1.90","article-title":". Comparative model-based analysis of screening programs for Chlamydia trachomatis infections.","volume":"153","author":"Kretzschmar","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R5-8-20210213","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/sti.2005.019067","article-title":". Modelling the effectiveness of chlamydia screening in England.","volume":"82","author":"Turner","year":"2006","journal-title":"Sex Transm Infect"},{"key":"R7-8-20210213","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.epidem.2010.04.002","article-title":". Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes.","volume":"2","author":"Althaus","year":"2010","journal-title":"Epidemics"},{"key":"R8-8-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/589883","article-title":"Coverage is the key for effective screening of Chlamydia trachomatis in Australia.","volume":"198","author":"Regan","year":"2008","journal-title":"J Infect Dis"},{"key":"R9-8-20210213","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.olq.0000162367.39209.01","article-title":". Chlamydia screening of at-risk young women in managed health care: Characteristics of top-performing primary care offices.","volume":"32","author":"Ray","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R10-8-20210213","first-page":"362","article-title":"Chlamydia screening among sexually active young female enrollees of health plansUnited States, 2000-2007.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0749-3797(03)00025-4","article-title":"Standardized health plan reporting in four areas of preventive health care.","volume":"24","author":"Shih","year":"2003","journal-title":"Am J Prev Med"},{"key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archpedi.154.11.1108","article-title":"Screening for chlamydia in adolescents and young women.","volume":"154","author":"Mangione-Smith","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R13-8-20210213","first-page":"585","article-title":"Validation of data collection for the HEDIS performance measure on chlamydia screening in an MCO.","volume":"9","author":"Wei","year":"2003","journal-title":"Am J Manag Care"},{"key":"R14-8-20210213","first-page":"370","article-title":"CDC Grand Rounds: Chlamydia prevention: Challenges and strategies for reducing disease burden and sequelae.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R16-8-20210213","first-page":"435","article-title":". Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis.","volume":"28","author":"Tao","year":"2002","journal-title":"Jt Comm J Qual Improv"},{"key":"R17-8-20210213","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/aje\/kwh162","article-title":". Indirect estimation of Chlamydia screening coverage using public health surveillance data.","volume":"160","author":"Levine","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R18-8-20210213","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.olq.0000230437.79119.31","article-title":"Estimating chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States.","volume":"34","author":"Tao","year":"2007","journal-title":"Sex Transm Dis"},{"key":"R19-8-20210213","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-147-2-200707170-00173","article-title":"Screening for chlamydial infection: An evidence update for the U.S. Preventive Services Task Force.","volume":"147","author":"Meyers","year":"2007","journal-title":"Ann Intern Med"},{"key":"R20-8-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006.","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R21-8-20210213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/OLQ.0b013e31823e3009","article-title":". Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population.","volume":"39","author":"Scholes","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R25-8-20210213","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.39154.378079.BE","article-title":"Screening programmes for chlamydial infection: when will we ever learn","volume":"334","author":"Low","year":"2007","journal-title":"BMJ"},{"key":"R26-8-20210213","first-page":"5","article-title":"Current status of chlamydia screening in Europe.","volume":"8","author":"Low","year":"2004","journal-title":"Euro Surveill"},{"key":"R27-8-20210213","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/OLQ.0b013e3182383097","article-title":". Who participates in the Dutch chlamydia screening A study on demographic and behavioral correlates of participation and positivity.","volume":"39","author":"Op de Coul","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R28-8-20210213","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/OLQ.0b013e31821597ca","article-title":". Will chlamydia screening reach young people in deprived areas in England Baseline analysis of the English National Chlamydia Screening Programme delivery in 2008.","volume":"38","author":"Sheringham","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R29-8-20210213","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/caac.20096","article-title":". Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.","volume":"61","author":"Smith","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R30-8-20210213","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/OLQ.0b013e31823e2ff7","article-title":". Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.","volume":"39","author":"Datta","year":"2012","journal-title":"Sex Transm Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0b013e3182809776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:57:24Z","timestamp":1620968244000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201304000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182809776","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}